Belmont Capital LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 2,620 shares of the company's stock, valued at approximately $905,000.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Cheviot Value Management LLC purchased a new position in shares of HCA Healthcare in the 1st quarter worth about $26,000. Saudi Central Bank purchased a new position in HCA Healthcare in the first quarter worth about $26,000. WPG Advisers LLC purchased a new stake in shares of HCA Healthcare during the first quarter valued at approximately $27,000. Atwood & Palmer Inc. bought a new position in HCA Healthcare in the 1st quarter valued at approximately $28,000. Finally, Bartlett & CO. Wealth Management LLC increased its holdings in shares of HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after purchasing an additional 80 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.
HCA Healthcare Stock Up 2.2%
NYSE HCA traded up $9.09 during midday trading on Friday, hitting $420.68. 1,059,770 shares of the company traded hands, compared to its average volume of 1,054,336. The company has a market cap of $98.44 billion, a PE ratio of 17.68, a price-to-earnings-growth ratio of 1.29 and a beta of 1.41. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $420.98. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. The company's 50-day simple moving average is $380.14 and its 200-day simple moving average is $359.85.
HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.
HCA Healthcare Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.
Wall Street Analysts Forecast Growth
HCA has been the topic of several research analyst reports. JPMorgan Chase & Co. upped their target price on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. Truist Financial raised their price target on HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research note on Wednesday, July 16th. Bank of America cut HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 target price on the stock. in a research report on Wednesday, July 16th. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Finally, Robert W. Baird boosted their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a research report on Thursday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $401.83.
Read Our Latest Research Report on HCA Healthcare
HCA Healthcare Company Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Further Reading
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
